Year Established :
1971
Total Number of Staff :
more than 1000
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Vital Commitment to our Partners and Projects
Comprehensive Technical and Regulatory Support
Over 80 DMFs / CEPs
First-to-Market Products
50 Years Industry Experience
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
Bachem is the world´s leading independent manufacturer of peptide active pharmaceutical ingredients (APIs) and a well established manufacturer of small molecules APIs. Each year, Bachem manufactures hundreds of batches of drug substance for projects in clinical trials and for products on the market.
Bachem is currently involved in ~ 150 cGMP development projects targeting NCEs and Bachem offers a range of more than 30 generic drug substances. We have the capacity to produce peptide APIs from gram scale up to annual quantities of hundreds of kilograms and small molecules APIs from gram scale up to annual quantities of tens of tons. Our GMP manufacturing facilities are located in Switzerland and the United States and are regularly inspected by the FDA and local authorities.